Korro Bio Inc (KRRO) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues | - | - | - | 1.29 | 1.09 |
8.22%18.46 | 20.11 | 20.44 | 51.69 | 20.33 | |
| Research and Development | 10.92%12.10 | 13.59 | 12.95 | 10.99 | 13.82 |
| Operating Income/Loss | 8.22%-18.46 | -20.11 | -20.44 | -50.40 | -19.24 |
| Income/Loss From Continuing Operations Before Tax | 8.08%-17.29 | -18.81 | -19.53 | -49.41 | -18.06 |
| Income Tax Expense/Benefit | 140.74%0.26 | 0.11 | 0.10 | 0.64 | - |
7.23%-17.55 | -18.92 | -19.63 | -50.04 | -18.06 | |
| Attributable To Parent | 7.23%-17.55 | -18.92 | -19.63 | -50.04 | -18.06 |
| Basic Average Shares | 1.41%17.87 | 17.62 | 11.60 | - | 9.39 |
| Diluted Average Shares | 1.41%17.87 | 17.62 | 11.60 | - | 9.39 |
| Basic Earnings Per Share | 8.41%-0.98 | -1.07 | -1.69 | - | -1.92 |
| Diluted Earnings Per Share | 8.41%-0.98 | -1.07 | -1.69 | - | -1.92 |